RADNET INC
RDNTNASDAQTrading Snapshot
- Day Range
- $70.23 β $71.33
- 52-Week Range
- $50.82 β $85.84
- Volume
- $3.36B
- Avg Volume
- $4.44B
- Shares Outstanding
- 78.6M
- Next Earnings
- Oct 19, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.04B
- Last Q Revenue
- $623M
- P/E Ratio
- β
- P/S Ratio
- 2.4x
- EPS (TTM)
- $-0.28
- Dividend Yield
- β
- Dilution (1yr)
- β0.5%
Why Investors Own RDNT
- βHigh-growth profile β revenue up +27.5% YoY with expanding US Equity exposure.
- βHealthy economics β 34% gross margin and 8% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
RADNET INC
RDNTAbout RADNET INC
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Engineers Gate Manager LP Acquires New Holdings in RadNet, Inc. $RDNT
Engineers Gate Manager LP acquired a new position in RadNet, Inc. (NASDAQ: RDNT) in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund ac

RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
RadNet, Inc. (RDNT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatien

RadNet to Host Free Prostate Cancer Webinar on September 19, 2026
LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 outpati

RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026
LOS ANGELES, Sept. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatien

Bamco Inc. NY Invests $77.77 Million in RadNet, Inc. $RDNT
Bamco Inc. NY acquired a new stake in RadNet, Inc. (NASDAQ: RDNT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,260